首页> 外文期刊>Toxicology and Applied Pharmacology >Metabolomic and proteomic biomarkers for III-V semiconductors: chemical-specific porphyrinurias and proteinurias.
【24h】

Metabolomic and proteomic biomarkers for III-V semiconductors: chemical-specific porphyrinurias and proteinurias.

机译:III-V族半导体的代谢组学和蛋白质组学生物标记物:化学特异性卟啉尿症和蛋白尿症。

获取原文
获取原文并翻译 | 示例
           

摘要

A pressing need exists to develop and validate molecular biomarkers to assess the early effects of chemical agents, both individually and in mixtures. This is particularly true for new and chemically intensive industries such as the semiconductor industry. Previous studies from this laboratory and others have demonstrated element-specific alterations of the heme biosynthetic pathway for the III-V semiconductors gallium arsenide (GaAs) and indium arsenide (InAs) with attendant increased urinary excretion of specific heme precursors. These data represent an example of a metabolomic biomarker to assess chemical effects early, before clinical disease develops. Previous studies have demonstrated that the intratracheal or subcutaneous administration of GaAs and InAs particles to hamsters produces the induction of the major stress protein gene families in renal proximal tubule cells. This was monitored by 35-S methionine labeling of gene products followed by two-dimensional gel electrophoresis after exposure to InAs particles. The present studies examined whether these effects were associated with the development of compound-specific proteinuria after 10 or 30 days following subcutaneous injection of GaAs or InAs particles in hamsters. The results of these studies demonstrated the development of GaAs- and InAs-specific alterations in renal tubule cell protein expression patterns that varied at 10 and 30 days. At the 30-day point, cells in hamsters that received InAs particles showed marked attenuation of protein expression, suggesting inhibition of the stress protein response. These changes were associated with GaAs and InAs proteinuria patterns as monitored by two-dimensional gel electrophoresis and silver staining. The intensity of the protein excretion patterns increased between the 10- and 30-day points and was most pronounced for animals in the 30-day InAs treatment group. No overt morphologic signs of cell death were seen in renal tubule cells of these animals. Western blot analyses of the urines with antibodies to the 32-, 70-, and 90-kDa stress protein families did not show the presence of these molecules, indicating that these proteins were not excreted in the urine samples. These data suggest that the observed proteinuria patterns were not a result of cell death and that the observed chemical-specific proteinurias were produced before marked cellular toxicity. These findings suggest a hypothesis involving GaAs and InAs interference with stress protein chaperoning of reabsorbed proteins for proteosomic degradation and the probable chaperoning of damaged intracellular proteins from renal proximal tubule cells into the urinary filtrate. Overall, the results of these studies provide further information on the nephrotoxicity of these semiconductor compounds. They also suggest the use of two-dimensional gel electrophoresis with silver staining of urinary protein patterns as a potentially useful proteomic approach to renal damage early in relation to intracellular proteotoxicity in kidney tubule cells.
机译:迫切需要开发和验证分子生物标记物,以评估化学试剂的单独或混合物的早期作用。对于新的和化学密集型行业,例如半导体行业,尤其​​如此。该实验室和其他实验室的先前研究表明,III-V族半导体砷化镓(GaAs)和砷化铟(InAs)的血红素生物合成途径具有特定于元素的变化,伴随着特定血红素前体的尿排泄增加。这些数据代表了一种代谢组学生物标志物的例子,可以在临床疾病发展之前及早评估化学作用。先前的研究表明,向仓鼠气管内或皮下施用GaAs和InAs颗粒可诱导肾近端小管细胞中主要应激蛋白基因家族的诱导。通过对基因产物进行35-S蛋氨酸标记来监测,然后在暴露于InAs颗粒后进行二维凝胶电泳。本研究检查了在皮下注射仓鼠中的GaAs或InAs颗粒后10或30天后,这些作用是否与化合物特异性蛋白尿的发展有关。这些研究的结果表明,在10天和30天时,肾小管细胞蛋白质表达模式中GaAs和InAs特异性改变的发展。在第30天时,仓鼠中接受InAs颗粒的细胞显示出明显的蛋白表达减弱,表明抑制了应激蛋白反应。这些变化与二维凝胶电泳和银染监测的GaAs和InAs蛋白尿模式有关。蛋白质排泄模式的强度在10天和30天之间增加,并且对于30天InAs治疗组中的动物最为明显。在这些动物的肾小管细胞中未见明显的细胞死亡形态学迹象。用针对32kDa,70kDa和90kDa应激蛋白家族的抗体对尿液进行的蛋白质印迹分析未显示出这些分子的存在,表明这些蛋白质并未在尿液样本中排泄。这些数据表明,观察到的蛋白尿模式不是细胞死亡的结果,并且观察到的化学特异性蛋白尿是在明显的细胞毒性之前产生的。这些发现提出了一个假说,其中涉及GaAs和InAs干扰重吸收蛋白的蛋白伴侣蛋白以进行蛋白质组学降解,以及受损的细胞内蛋白从肾脏近端肾小管细胞进入尿液滤液的假说。总体而言,这些研究的结果提供了有关这些半导体化合物的肾毒性的进一步信息。他们还建议使用二维凝胶电泳结合尿蛋白模式的银染,作为与肾小管细胞内细胞内蛋白毒性有关的早期潜在的有用的蛋白质组学方法来治疗肾脏损害。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号